Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors

被引:127
作者
Heery, DM
Hoare, S
Hussain, S
Parker, MG
Sheppard, H
机构
[1] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England
[2] Imperial Canc Res Fund, London WC2A 3PX, England
关键词
D O I
10.1074/jbc.M009404200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An alpha -helical motif containing the sequence LXXLL is required for the ligand-dependent binding of transcriptional co-activators to nuclear receptors. By using a peptide inhibition assay, we have defined the minimal "core" LXXLL motif as an 8-amino acid sequence spanning positions -2 to +6 relative to the primary conserved leucine residue. In yeast two-hybrid assays, core LXXLL motif sequences derived from steroid receptor co-activator (SRC1), the 140-kDa receptor interacting protein (RIP140), and CREB-binding protein (CBP) displayed differences in selectivity and affinity for nuclear receptor ligand binding domains. Although core LXXLL motifs from SRC1 and RIP140 mediated strong interactions with steroid and retinoid receptors, three LXXLL motifs present in the global co-activator CBP were found to have very weak affinity for these proteins. Core motifs with high affinity for steroid and retinoid receptors were generally found to contain a hydrophobic residue at position -1 relative to the first conserved leucine and a nonhydrophobic residue at position +2. Our results indicate that variant residues in LXXLL core motifs influence the affinity and selectivity of co-activators for nuclear receptors.
引用
收藏
页码:6695 / 6702
页数:8
相关论文
共 51 条
[1]  
Bevan CL, 1999, MOL CELL BIOL, V19, P8383
[2]   Cloning and characterization of RAP250, a novel nuclear receptor coactivator [J].
Caira, F ;
Antonson, P ;
Pelto-Huikko, M ;
Treuter, E ;
Gustafsson, JÅ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) :5308-5317
[3]   Role of CBP/P300 in nuclear receptor signalling [J].
Chakravarti, D ;
LaMorte, VJ ;
Nelson, MC ;
Nakajima, T ;
Schulman, IG ;
Juguilon, H ;
Montminy, M ;
Evans, RM .
NATURE, 1996, 383 (6595) :99-103
[4]  
Chang CY, 1999, MOL CELL BIOL, V19, P8226
[5]   Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase [J].
Chen, HW ;
Lin, RJ ;
Xie, W ;
Wilpitz, D ;
Evans, RM .
CELL, 1999, 98 (05) :675-686
[6]   Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 [J].
Chen, HW ;
Lin, RJ ;
Schiltz, RL ;
Chakravarti, D ;
Nash, A ;
Nagy, L ;
Privalsky, ML ;
Nakatani, Y ;
Evans, RM .
CELL, 1997, 90 (03) :569-580
[7]   Structure and specificity of nuclear receptor-coactivator interactions [J].
Darimont, BD ;
Wagner, RL ;
Apriletti, JW ;
Stallcup, MR ;
Kushner, PJ ;
Baxter, JD ;
Fletterick, RJ ;
Yamamoto, KR .
GENES & DEVELOPMENT, 1998, 12 (21) :3343-3356
[8]   Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities [J].
Ding, XF ;
Anderson, CM ;
Ma, H ;
Hong, H ;
Uht, RM ;
Kushner, PJ ;
Stallcup, MR .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (02) :302-313
[9]   p300 functions as a coactivator for the peroxisome proliferator-activated receptor α [J].
Dowell, P ;
Ishmael, JE ;
Avram, D ;
Peterson, VJ ;
Nevrivy, DJ ;
Leid, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (52) :33435-33443
[10]   p300 interacts with the N- and C-terminal part of PPARγ2 in a ligand-independent and -dependent manner, respectively [J].
Gelman, L ;
Zhou, GC ;
Fajas, L ;
Raspé, E ;
Fruchart, JC ;
Auwerx, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) :7681-7688